These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28926547)

  • 21. Clinical significance of "cannibalism" in urinary cytology of bladder cancer.
    Kojima S; Sekine H; Fukui I; Ohshima H
    Acta Cytol; 1998; 42(6):1365-9. PubMed ID: 9850644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.
    Yamamoto Y; Matsuyama H; Chochi Y; Okuda M; Kawauchi S; Inoue R; Furuya T; Oga A; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2007 Apr; 174(1):42-7. PubMed ID: 17350465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.
    Li C; Wu S; Wang H; Bi X; Yang Z; Du Y; He L; Cai Z; Wang J; Fan Z
    Oncotarget; 2015 Aug; 6(23):19542-51. PubMed ID: 26143634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
    Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
    Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells.
    Yang Z; He L; Lin K; Zhang Y; Deng A; Liang Y; Li C; Wen T
    Clin Cancer Res; 2017 Nov; 23(21):6673-6685. PubMed ID: 28765327
    [No Abstract]   [Full Text] [Related]  

  • 27. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
    Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24.
    Ning ZF; Huang YJ; Lin TX; Zhou YX; Jiang C; Xu KW; Huang H; Yin XB; Huang J
    J Int Med Res; 2009; 37(3):621-30. PubMed ID: 19589244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-Renewal and Tumor-Initiating Capacity of Bladder Cancer Stem Cells.
    Li C; Du Y; Yang Z; He L; Wang Y; Hao L; Ding M; Yan R; Wang J; Fan Z
    Cancer Res; 2016 Mar; 76(5):1273-83. PubMed ID: 26676748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer: Resistance through repopulation.
    Tannock IF
    Nature; 2015 Jan; 517(7533):152-3. PubMed ID: 25470047
    [No Abstract]   [Full Text] [Related]  

  • 31. The granulocyte macrophage-colony stimulating factor surface modified MB49 bladder cancer stem cells vaccine against metastatic bladder cancer.
    Zhu YT; Zhao Z; Fu XY; Luo Y; Lei CY; Chen W; Li F; Pang SY; Chen SS; Tan WL
    Stem Cell Res; 2014 Jul; 13(1):111-22. PubMed ID: 24874290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
    Zhu XX; Yan YW; Ai CZ; Jiang S; Xu SS; Niu M; Wang XZ; Zhong GS; Lu XF; Xue Y; Tian S; Li G; Tang S; Jiang YZ
    Oncotarget; 2017 Apr; 8(15):24483-24490. PubMed ID: 28445934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.
    Zhu YT; Pang SY; Lei CY; Luo Y; Chu QJ; Tan WL
    Stem Cell Res Ther; 2015 Nov; 6():224. PubMed ID: 26566931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway.
    Wang D; Kong X; Li Y; Qian W; Ma J; Wang D; Yu D; Zhong C
    Biochem Biophys Res Commun; 2017 Nov; 493(1):521-527. PubMed ID: 28870814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
    Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.
    Shen H; Blijlevens M; Yang N; Frangou C; Wilson KE; Xu B; Zhang Y; Zhang L; Morrison CD; Shepherd L; Hu Q; Zhu Q; Wang J; Liu S; Zhang J
    Int J Biol Sci; 2015; 11(12):1363-75. PubMed ID: 26681916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
    Koukourakis MI; Kakouratos C; Kalamida D; Bampali Z; Mavropoulou S; Sivridis E; Giatromanolaki A
    Int J Radiat Biol; 2016 Jul; 92(7):353-63. PubMed ID: 27010533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified method by differential adhesion for enrichment of bladder cancer stem cells.
    Zhu YT; Pang SY; Luo Y; Chen W; Bao JM; Tan WL
    Int Braz J Urol; 2016; 42(4):817-24. PubMed ID: 27564296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.